Bitcoin Generation Inc. (BTGN)

[beentomyrasite]

IS IT INOL!!! Biotech Ready to Rocket



A Real Cancer Breakthrough and the Small Biotech Set to Rocket...
By Jessica Comitto
August 30, 2011

Dear Penny Sleuther,

According to the American Cancer Society, half of all men and one- third of all women in the US will develop some form cancer during their lifetimes...

Yesterday, Pfizer announced they received FDA approval for their new lung cancer treatment, XALKORI. Today the stock jumped up 2.64% within minutes of the open.

But you’re a Sleuther — you aren’t going to want to invest in a big pharmaceutical company like Pfizer... you want truly explosive gains.

On August 11 the University of Pennsylvania released data on the successful treatment of three leukemia patients, proving they can now make blood cells specific to each patient and arm them to fight cancer.

The results of the study are revolutionary. And science is moving in the right direction.

But there’s a snag.

“The use of gene therapies using patients’ individual genes is,” Patrick Cox, our in-house biotech expert “is, obviously, not the best solution for treating cancers. To keep costs and delays down, we need off-the-shelf products.”

“Regenerative medicine” is the exception to that rule.

The results of this study are ground-breaking, but the treatment would be very expensive. You couldn’t just walk in and receive the treatment like you would go in to get a cavity filled. Doctors would have to personalize the treatment for every individual that walked in the door.

What we need is a solution that could help many... not only the very wealthy....



Jessica Comitto
Managing Editor, Penny Sleuth